PubRank

A Rimola

Author PubWeight™ 126.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993 3.28
2 Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987 3.01
3 Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001 2.73
4 Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. Gastroenterology 1990 2.31
5 Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994 2.27
6 Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology 1996 2.00
7 Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999 1.92
8 Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol 2001 1.89
9 Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. Am J Transplant 2008 1.86
10 Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 1998 1.83
11 Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant 2011 1.78
12 Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988 1.76
13 Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988 1.73
14 Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984 1.73
15 Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 2007 1.69
16 Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology 1993 1.67
17 Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 1990 1.63
18 Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998 1.60
19 Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation. Am J Transplant 2011 1.54
20 Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 1985 1.50
21 Cyclosporine-associated mutism in liver transplant patients. Neurology 1996 1.49
22 Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 1988 1.40
23 Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage. Hepatology 1984 1.36
24 Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites. Lancet 1985 1.36
25 Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system. Gastroenterology 1983 1.33
26 Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion. Cell Death Dis 2010 1.31
27 Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997 1.29
28 Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 1993 1.27
29 Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology 1987 1.23
30 Effects of renal impairment on liver transplantation. Gastroenterology 1987 1.23
31 Outcome of HCV/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study. Am J Transplant 2012 1.22
32 Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 1994 1.16
33 Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion. Eur J Clin Invest 1983 1.14
34 Esophageal tamponade for bleeding varices. Controlled trial between the Sengstaken-Blakemore tube and the Linton-Nachlas tube. Gastroenterology 1978 1.13
35 Liver transplant using donors after unexpected cardiac death: novel preservation protocol and acceptance criteria. Am J Transplant 2007 1.08
36 Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 1993 1.08
37 Diabetes mellitus after liver transplantation: prevalence and predictive factors. J Hepatol 1996 1.07
38 Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage. Gastroenterology 1982 1.07
39 Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites. Gastroenterology 1983 1.05
40 Hepatocellular oxidative stress and initial graft injury in human liver transplantation. J Hepatol 1999 1.04
41 Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991 1.03
42 Bacterial infections in liver disease. Semin Liver Dis 1997 1.02
43 Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 1985 1.02
44 Ascites after liver transplantation. Liver Transpl 2000 1.01
45 Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology 1992 1.00
46 Predictive factors of in-hospital CNS complications following liver transplantation. Neurology 1994 0.99
47 Outcome of autoimmune hepatitis after liver transplantation. Transplantation 1998 0.97
48 Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis. Am J Med 1986 0.97
49 Effect of demeclocycline on renal function and urinary prostaglandin E2 and kallikrein in hyponatremic cirrhotics. Nephron 1984 0.97
50 Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 2001 0.96
51 Spontaneous bacterial peritonitis in liver cirrhosis: treatment and prophylaxis. Infection 1994 0.95
52 Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. Hepatology 2000 0.94
53 Gastrointestinal complications in liver transplant recipients: MITOS study. Transplant Proc 2007 0.94
54 Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Gastroenterology 1990 0.93
55 Matrix metalloproteinase 2 in reduced-size liver transplantation: beyond the matrix. Am J Transplant 2010 0.93
56 Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis. Kidney Int 1984 0.91
57 Intracellular IFN-γ and IL-2 expression monitoring as surrogate markers of the risk of acute rejection and personal drug response in de novo liver transplant recipients. Cytokine 2012 0.91
58 Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis. Hepatology 1985 0.90
59 Urinary excretion of 6-keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome). J Hepatol 1986 0.90
60 Intrahepatic biliary lesions after orthotopic liver transplantation. Transpl Int 2001 0.89
61 Selective intestinal decontamination in the prevention of bacterial infection in patients with acute liver failure. J Hepatol 1992 0.89
62 Liver transplantation in patients with non-biliary cirrhosis: prognostic value of preoperative factors. J Hepatol 1998 0.88
63 Role of ischemic preconditioning and the portosystemic shunt in the prevention of liver and lung damage after rat liver transplantation. Transplantation 2003 0.87
64 Bone fractures in liver transplant patients. Br J Rheumatol 1994 0.87
65 How ischaemic preconditioning protects small liver grafts. J Pathol 2006 0.87
66 The use of the saphenous vein for arterial reconstruction in orthotopic liver transplant. Transplant Proc 1990 0.87
67 Renal tubular acidosis in primary biliary cirrhosis. Gastroenterology 1981 0.86
68 Liver transplantation for acute liver failure: analysis of applicability. Gastroenterology 1993 0.85
69 Quality of life, major medical complications and hospital service utilization in patients with primary biliary cirrhosis after liver transplantation. J Hepatol 1996 0.85
70 Expanded liver donor age over 60 years for hepatic transplantation. Clin Transpl 1998 0.85
71 Hyperintensity in the globus pallidus on T1-weighted and inversion-recovery MRI: a possible marker of advanced liver disease. Neurology 1991 0.84
72 ATG-Fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation. Am J Transplant 2010 0.84
73 Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation. Liver Transpl 2001 0.84
74 Malakoplakia in the gastrointestinal tract of a liver transplant recipient. Transplantation 1995 0.84
75 Alternariosis after liver transplantation. Transplantation 2001 0.83
76 Liver transplantation in patients with Caroli's disease and recurrent cholangitis. Transpl Int 1997 0.83
77 Prostacyclin, thromboxane, and oxygen free radicals and postoperative liver function in human liver transplantation. Transplantation 1995 0.83
78 Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites. Nephron 1986 0.82
79 Influence of the dynamics of the hypervariable region 1 of hepatitis C virus (HCV) on the histological severity of HCV recurrence after liver transplantation. J Med Virol 2001 0.82
80 Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A. Calcif Tissue Int 2001 0.82
81 Endogenous nitric oxide and exogenous nitric oxide supplementation in hepatic ischemia-reperfusion injury in the rat. Transplantation 2001 0.82
82 Sacral stress fracture after liver transplantation. Br J Rheumatol 1993 0.81
83 Therapeutic targets in liver transplantation: angiotensin II in nonsteatotic grafts and angiotensin-(1-7) in steatotic grafts. Am J Transplant 2008 0.81
84 [Relation of the levels of systemic prostaglandins and hemodynamic changes present during orthotopic transplant of the liver]. Rev Esp Enferm Dig 1996 0.81
85 Renal kallikrein excretion in cirrhotics with ascites: relationship to renal hemodynamics. Hepatology 1984 0.80
86 Efficacy and safety of oral low-dose tacrolimus treatment in liver transplantation. Transpl Int 1998 0.80
87 Does previous abdominal surgery alter the outcome of pediatric patients subjected to orthotopic liver transplantation? Gastroenterology 1986 0.79
88 How Institut Georges Lopez preservation solution protects nonsteatotic and steatotic livers against ischemia-reperfusion injury. Transplant Proc 2011 0.79
89 One thousand liver transplants: the hospital clinic experience. Transplant Proc 2005 0.79
90 Rhodococcus equi infection after liver transplantation. Transplantation 1996 0.79
91 Does donor age exclude liver grafting? Transplant Proc 1993 0.78
92 Effect of venovenous bypass on perioperative renal function in liver transplantation: results of a randomized, controlled trial. Hepatology 1996 0.78
93 [Adult living donor liver transplantation. Analysis of the first 30 cases]. Gastroenterol Hepatol 2003 0.78
94 Five-year follow-up of a trial comparing Tacrolimus and cyclosporine microemulsion in liver transplantation. Transplant Proc 2005 0.78
95 Liver retransplantation in HIV-infected patients: a prospective cohort study. Am J Transplant 2012 0.78
96 Value of duplex-doppler ultrasound findings in liver transplant recipients with poor graft function. Transplantation 1996 0.78
97 Adenine nucleotides in liver tissue and organ viability in human liver transplantation. Transplant Proc 1992 0.78
98 The role of systemic prostaglandins during human liver transplantation. Ann N Y Acad Sci 1994 0.77
99 Clinical trial on the cost-effectiveness of T-tube use in an established deceased donor liver transplantation program. Clin Transplant 2007 0.77
100 How long should initiation of calcineurin inhibitors be delayed to protect renal function in liver transplantation? Transplant Proc 2011 0.77
101 Somatostatin therapy protects porcine livers in small-for-size liver transplantation. Am J Transplant 2014 0.77
102 Therapeutic drug monitoring of tacrolimus in liver transplantation, phase III FK506 multicenter Spanish Study Group: a two-year follow-up. Ther Drug Monit 1998 0.77
103 Study of liver preservation: efficacy of a combined method using the UW solution. Transplant Proc 1992 0.77
104 Cimetidine in acute gastric mucosal bleeding: results of a double-blind randomized trial. Dig Dis Sci 1980 0.77
105 Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients. Transplant Proc 2002 0.77
106 Renal effects of dietary supplementation with fish oil in cyclosporine-treated liver transplant recipients. Hepatology 1995 0.77
107 Effect of donor age on graft outcome after liver transplantation. Transplant Proc 1999 0.76
108 Venovenous bypass and liver transplantation. Anesth Analg 1993 0.76
109 The use of the University of Wisconsin (UW) and Euro-Collins (EC) solutions either alone or in a combined method. Transpl Int 1992 0.76
110 Liver transplantation for alcoholic cirrhosis with anti-HCV antibodies. Transpl Int 1997 0.76
111 Liver transplantation in hepatitis C. A Spanish multi-centre experience. Eur J Gastroenterol Hepatol 1998 0.76
112 Impact of donor gender on graft survival after liver transplantation. Transplant Proc 1997 0.76
113 Reduced doses of hepatitis B immunoglobulin protect against hepatitis B virus infection recurrence after liver transplantation. Transplant Proc 2001 0.76
114 Tauroursodeoxycholic acid affects PPARγ and TLR4 in Steatotic liver transplantation. Am J Transplant 2012 0.76
115 Living donor psychosocial assesment/follow-up practices in the partners' countries of the ELIPSY project. Transplant Proc 2012 0.75
116 Vena cava vascular reconstruction during orthotopic liver transplantation: a comparative study. Liver Transpl Surg 1998 0.75
117 Outcome of patients undergoing orthotopic liver transplantation with elderly donors (over 60 years). Transplant Proc 1997 0.75
118 Prognosis of hepatocarcinoma in liver transplantation in cirrhotic patients. Transplant Proc 1997 0.75
119 Cannulation of the inferior mesenteric vein for veno-venous bypass in human liver transplantation: a reliable procedure? Transplant Proc 1993 0.75
120 Comparative study of aminoglycoside nephrotoxicity in normal rats and rats with experimental cirrhosis. Hepatology 1988 0.75
121 [Technics for the study of the renal excretion of free water in normal rats and those with experimental liver cirrhosis]. Rev Esp Fisiol 1986 0.75
122 [Postoperative psychiatric complications following liver transplantation]. Med Clin (Barc) 1993 0.75
123 Rapidly cycling bipolar II disorder following liver transplantation. Gen Hosp Psychiatry 1993 0.75
124 Value of MEGX test in predicting survival after liver transplantation from non-heart-beating donor pigs. Transplant Proc 1997 0.75
125 Steroids and living liver donation increase tacrolimus blood levels in living donor liver transplantation. Transplant Proc 2005 0.75
126 [Endotoxin and hepatic cirrhosis]. Med Chir Dig 1979 0.75
127 Impact of health related quality of life in Catalonia liver transplant patients. Transplant Proc 2009 0.75
128 [Pneumocystis carinii pneumonia in the transplant recipient]. Enferm Infecc Microbiol Clin 1996 0.75
129 Formaldehyde chemistry in cometary ices: the case of HOCH2OH formation. Phys Chem Chem Phys 2014 0.75
130 Effects of intravenous amino acid infusion and dietary proteins on kidney function in cirrhosis. Hepatology 1990 0.75
131 Erythromycin ototoxicity in liver transplant patients. Transpl Int 1994 0.75
132 [Liver transplantation: candidate selection and results of a program for adult patients]. Med Clin (Barc) 1991 0.75
133 Intrahepatic biliary lesions and ABO incompatibility after liver transplantation. Transplant Proc 1993 0.75
134 Use of perihepatic packing in the management of intraoperative hemorrhage in liver transplantation. Transplant Proc 1999 0.75
135 Liver function test and prevalence of associated diseases 5 years after liver transplantation. Transplant Proc 2002 0.75
136 [Determination of the concentration of gentamycin in the renal tissue of rats by radioimmunoassay]. Arch Farmacol Toxicol 1984 0.75
137 Improvement in correlation between oral dose of cyclosporine and cyclosporinemia after substitution of conventional cyclosporine by Neoral cyclosporine in 296 liver transplant patients. Transplant Proc 1998 0.75
138 [Ischemia-reperfusion syndrome associated with liver transplantation: an update]. Gastroenterol Hepatol 2006 0.75
139 [Infectious complications associated with liver transplantation: analysis of 104 patients]. Gastroenterol Hepatol 2001 0.75
140 Recovery of liver graft after initial poor function. Transplantation 1992 0.75
141 [Living donor liver transplantation in adults]. Gastroenterol Hepatol 2002 0.75
142 Outcome after liver transplantation. Differences between two time periods: 1988-1991 and 1992-1995. Transplant Proc 1997 0.75
143 Combined liver-kidney transplantation: our experience. Transplant Proc 1999 0.75
144 Adult living donor liver transplantation: initial results of a starting program. Transplant Proc 2002 0.75
145 [Prolonged administration of hepatitis B hyperimmune gamma globulin in patients with liver transplantation in liver diseases caused by hepatitis B virus]. Gastroenterol Hepatol 1996 0.75
146 Routine use of the T tube in the biliary reconstruction of liver transplantation: is it worthwhile? Transplant Proc 1999 0.75
147 [Living donor liver transplantation in adults. Initial results]. Gastroenterol Hepatol 2001 0.75
148 Lack of renal effects of fish oil administration in patients with advanced cirrhosis and impaired glomerular filtration. Hepatology 1997 0.75
149 Kayser-Fleischer-like ring in a cryptogenic cirrhosis. Arch Intern Med 1978 0.75
150 Does Fe(2+) in olivine-based interstellar grains play any role in the formation of H2? Atomistic insights from DFT periodic simulations. Chem Commun (Camb) 2016 0.75
151 Prostaglandin metabolism and hemodynamic alterations during human liver transplantation. Transplant Proc 1993 0.75
152 Study of liver preservation: the use of University of Wisconsin or Euro-Collins solutions alone or in a combined method. Transplant Proc 1991 0.75
153 Renal failure in cirrhosis and liver transplantation. Transplant Proc 1993 0.75
154 Urinary beta 2-microglobulin and serum bilirubin concentrations in hepatorenal syndrome and acute tubular necrosis. Hepatology 1986 0.75
155 [Liver transplantation: who and when]. Med Clin (Barc) 1991 0.75
156 Risk factors for severe bacterial infection after liver transplantation. Transplant Proc 1995 0.75
157 Prostaglandin and lipoperoxide levels and postoperative liver function in human liver transplantation. Transplant Proc 1994 0.75
158 Prostaglandins and renal function in cirrhosis. Prog Liver Dis 1986 0.75
159 Evaluation of ischemic liver injury during graft procurement from non-heart-beating donor pigs. Transplant Proc 1997 0.75
160 [Specificity of the determination of urinary kallikrein activity using an amidolytic assay]. Rev Esp Fisiol 1983 0.75
161 The process of adult living liver donation. Transplant Proc 2003 0.75
162 [Hepatitis C virus in liver transplantation]. Gastroenterol Hepatol 1999 0.75
163 [De novo tumors in adult patients with hepatic transplant]. Gastroenterol Hepatol 1997 0.75
164 [Determination of arginine-vasopressin in small volumes of rat plasma]. Rev Esp Fisiol 1986 0.75